BlackRock
ONCR

BlackRock’s Oncorus, Inc. ONCR Stock Holding History

BlackRock’s Portfolio ONCR Stock Details ONCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-139,040
Closed -$47.8K – 5655
2023
Q1 		$47.8K Sell
139,040
-632
-0.5% -$236 ﹤0.01% 5129
2022
Q4 		$35.4K Sell
139,672
-132,692
-49% -$75.5K ﹤0.01% 5291
2022
Q3 		$231K Sell
272,364
-6,376
-2% -$8.18K ﹤0.01% 4943
2022
Q2 		$352K Sell
278,740
-1,051,796
-79% -$1.43M ﹤0.01% 4876
2022
Q1 		$2.37M Sell
1,330,536
-23,473
-2% -$65.8K ﹤0.01% 4319
2021
Q4 		$7.13M Buy
1,354,009
+248,560
+22% +$1.92M ﹤0.01% 3843
2021
Q3 		$10.3M Sell
1,105,449
-1,769
-0.2% -$20.2K ﹤0.01% 3657
2021
Q2 		$15.3M Buy
1,107,218
+744,200
+205% +$11.5M ﹤0.01% 3451
2021
Q1 		$5.05M Buy
363,018
+35,297
+11% +$731K ﹤0.01% 3937
2020
Q4 		$10.6M Buy
+327,721
New +$7.59M ﹤0.01% 3325

Other funds holding ONCR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
YAL
Your Advocates Ltd Houston, Texas $328M AUM 19.81% 1-Year Est. Return